Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Houston, Louisiana Clinical Trials

A listing of Houston, Louisiana clinical trials actively recruiting patient volunteers.

RESULTS

Found (68) clinical trials

Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rez m XL)

Prospective, multicenter, single arm clinical trial designed to evaluate the safety of the Rezm System in treating subjects with symptomatic BPH for prostate sizes >80cm3 and 150 cm3.

Phase N/A

4.11 miles

Learn More »

Single Arm Study of 6-Months Neoadjuvant ARN-509 Prior to Radical Prostatectomy

Study Drug Administration: If you are found to be eligible to take part in the study, you will take 4 tablets of apalutamide by mouth each day for a total of 24 weeks (about 6 months) leading up to your standard-of-care prostate surgery. You should take apalutamide at about the ...

Phase

4.11 miles

Learn More »

Lifestyle Intervention and Testosterone Replacement in Obese Seniors

Obesity is not only highly prevalent among Americans, but even more so among Veterans using VA medical facilities. Failure to assist Veterans in managing weight and sedentary lifestyle affects current treatment and increases future demand for VA health care services. Decreased muscle mass with aging and the need to carry ...

Phase

4.11 miles

Learn More »

A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

This multicenter study will evaluate safety and efficacy of niraparib in combination with other anti-cancer agents. The first combination study will combine niraparib with the anti-programmed cell death protein (PD)-1 monoclonal antibody, JNJ-63723283 (niraparib combination therapies) in participants with metastatic castration-resistant prostate cancer. This study will be conducted in 2 ...

Phase

4.11 miles

Learn More »

Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism

After age of 40, testosterone (T) production in men gradually decreases at a rate of 1.6% per year for total and to 2-3% per year for bioavailable T. This reduction in T production in men parallels the age-associated loss of muscle mass that leads to sarcopenia and impairment of function ...

Phase

4.11 miles

Learn More »

HOUSTON - HPV-related Oropharyngeal and Uncommon Cancers Screening Trial Of Men

If you are eligible to take part in this study, and you agree, you will be screened for cancer and/or dysplasia (a type of pre-cancerous lesion). These visits will be at MD Anderson. You may refuse taking part in any part of the screening procedures or stop taking part in ...

Phase N/A

4.11 miles

Learn More »

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Sensitive Prostate Cancer Previously Treated With Docetaxel

PRIMARY OBJECTIVES: I. To assess whether the addition of 6 cycles of cabazitaxel to abiraterone acetate in patients with castration-resistant prostate cancer (CRPC) that have previously received docetaxel and androgen deprivation therapy (ADT) for hormone-sensitive prostate cancer (HSPC) can improve progression-free survival (PFS) compared to abiraterone acetate alone. SECONDARY OBJECTIVES: ...

Phase

4.11 miles

Learn More »

H-22411: BOTOX for Peyronie's Disease

Treatments for this disease have been limited and often unsuccessful. The goal of treatment is to reduce pain and maintain sexual function. Oral medicines that prevent plaque formation and promote plaque breakdown have not been effective. Many patients with the disease will require injections of medicines directly into the plaque. ...

Phase

4.11 miles

Learn More »

Screening for Bladder Cancer

Reduction of cancer mortality is a stated goal of the National Cancer Institute. Cancer of the bladder is the 4th most commonly diagnosed cancer and 7th leading cause of cancer death in the American men, and represents an important target for mortality-reducing efforts. Furthermore, these tumors, even in early (i.e. ...

Phase N/A

4.11 miles

Learn More »

Multi-Institutional Registry for Prostate Cancer Radiosurgery

To address pertinent questions regarding the utilization of radiosurgery (SBRT) to treat prostate cancer. The Florida Robotic Radiosurgery Association (FRRA) launched the first registry for prostate cancer patients treated with SBRT. The registry is designed to track surrogate treatment endpoints including PSA, IPSS, SHIM, QOL, Karnofsky Performance Status, VAS scores, ...

Phase N/A

4.11 miles

Learn More »